|
131
|
|
|
Potassium inwardly rectifying channel subfamily J member 6 |
BIR1, GIRK-2, GIRK2, KATP-2, KATP2, KCNJ7, KIR3.2, KPLBS, hiGIRK2 |
Appendicitis, Attention deficit hyperactivity disorder, Autism, Breast cancer, Cholecystitis, Cholecystolithiasis, Color vision deficiency, Coronary artery disease, Dementia, Major depressive disorder, Gout, Keppen-lubinsky syndrome, Depression, Metabolic syndrome, Parkinson disease, Retinal degeneration, Schizophrenia, Stroke, Substance abuse, Diabetes mellitus, type 2View all (5 more) |
|
132
|
|
|
Potassium inwardly rectifying channel subfamily J member 8 |
KIR6.1, uKATP-1 |
|
|
133
|
|
|
Potassium inwardly rectifying channel subfamily J member 10 |
BIRK-10, KCNJ13-PEN, KIR1.2, KIR4.1, SESAME |
Nonsyndromic hearing loss, Cerebellar ataxia, Congenital neurologic anomalies , Deafness, East syndrome, Intellectual developmental disorder, Littles disease, Multiple sclerosis, Paroxysmal dystonic choreoathetosis, Paroxysmal dyskinesia, Pendred syndrome, Peripheral neuropathy, Seizures, tonic-clonic, photosensitive |
|
134
|
|
|
Potassium inwardly rectifying channel subfamily J member 11 |
BIR, HHF2, IKATP, KIR6.2, MODY13, PHHI, PNDM2, TNDM3 |
Hyperinsulinism, Congenital microcephaly, Coronary artery disease, Dend syndrome, Atopic dermatitis, Diabetes mellitus, Experimental diabetes, Diabetes mellitus type 1, Diabetes mellitus type 2, Diabetes mellitus permanent neonatal, Diabetes mellitus transient neonatal, Hyperinsulinemic hypoglycemia, Hypertrichosis, Hypoglycemia, Diabetes mellitus, type 2, Neonatal diabetes mellitus, Maturity-onset diabetes of the young (mody), Maturity-onset diabetes of the young, Psoriasis, SeizuresView all (5 more) |
|
135
|
|
|
Potassium inwardly rectifying channel subfamily J member 13 |
KIR1.4, KIR7.1, LCA16, SVD |
|
|
136
|
|
|
Potassium inwardly rectifying channel subfamily J member 15 |
IRKK, KIR1.3, KIR4.2 |
|
|
137
|
|
|
Potassium two pore domain channel subfamily K member 1 |
DPK, HOHO, K2P1, K2p1.1, KCNO1, TWIK-1, TWIK1 |
|
|
138
|
|
|
Potassium two pore domain channel subfamily K member 2 |
K2p2.1, TPKC1, TREK, TREK-1, TREK1, hTREK-1c, hTREK-1e |
|
|
139
|
|
|
Potassium two pore domain channel subfamily K member 3 |
K2p3.1, OAT1, PPH4, TASK, TASK-1, TASK1, TBAK1 |
Cardiovascular disease, Cerebrovascular disorder, Corneal astigmatism, Coronary artery disease, Diverticular disease, Hypertension, Pulmonary hypertension, Heart failure, Pulmonary arterial hypertension, Major depressive disorder, Metabolic syndrome, Osteoarthritis, Potassium deficiency, Sarcoidosis, Stroke, Diabetes mellitus, type 2View all (1 more) |
|
140
|
|
|
Potassium calcium-activated channel subfamily M alpha 1 |
BKTM, CADEDS, IEG16, KCa1.1, LIWAS, MaxiK, PNKD3, SAKCA, SLO, SLO-ALPHA, SLO1, bA205K10.1, hSlo, mSLO1 |
Alzheimer disease, Androgenetic alopecia, Angioedema, Autism, Bell's palsy, Bone disease, Renal cell carcinoma, Cerebellar atrophy with seizures and variable developmental delay, Color vision deficiency, Generalized epilepsy, Idiopathic generalized epilepsy, Eye disease, Gingival diseases, Global developmental delay, Growth disorder, Pulmonary hypertension, Hypospadias, Intellectual developmental disorder, Lung cancer, Metabolic bone disorder, Metabolic syndrome, Obesity, Nonalcoholic fatty liver disease, Non-melanoma skin carcinoma, Osteoarthritis, Osteonecrosis, Paroxysmal nonkinesigenic dyskinesia, Willis-ekbom disease, Schizophrenia, Severe acute respiratory syndrome, Spastic ataxia, Status epilepticus, Diabetes mellitus, type 2View all (18 more) |